Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

EpimedX featured in OK Magazine

Get in Touch

EpimedX is one of i2E’s most exciting and promising client companies.  It is developing a treatment for Sickle Cell Disease that can actually reverse the condition by restoring what is known as fetal hemoglobin in patients.

Oklahoma Magazine recently featured the company and co-founder Dr. Robert Broyles in its April editions.  Here is the lead to the story and a link to the whole article at the magazine website:

THE CELL HUNTER

By Paul Fairchild

Copyright © 2013 Schuman Publications. All rights reserved.

Longtime OU professor, Dr. Robert Broyles, is a hunter. One of the world’s deadliest scourges, sickle cell anemia, sits squarely in his sights. He recently founded EpimedX, an Oklahoma City company that will enable him to pull the trigger. After 20 years in the blind, the geneticist and his colleagues are roughly 10 years away from firing the magic bullet that will put sickle cell anemia down once and for all.

Taking down sickle cell anemia is a lofty goal. Broyles’ goals for his cure are equally lofty and go beyond saving lives. “This will change the lives of individuals with sickle cell disease in third world countries. Children born in those countries with sickle cell anemia almost always die before they turn 5,” he says, “It’s a life or death thing for those people. In the U.S., where every baby born is tested for the disease, we’re able to identify them early. They don’t die as young, but they’ll still have serious health issues and painful lives. They’re always in crisis, in and out of emergency rooms. It’s hard for a person in that situation to get an education, much less hold a job. It’s not just a health issue.”

Click here to read the entire article at the OK Magazine website.

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E